BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16797080)

  • 1. Antidepressant withdrawal symptoms-telephone calls to a national medication helpline.
    Taylor D; Stewart S; Connolly A
    J Affect Disord; 2006 Oct; 95(1-3):129-33. PubMed ID: 16797080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant discontinuation: a review of the literature.
    Lejoyeux M; Adès J
    J Clin Psychiatry; 1997; 58 Suppl 7():11-5; discussion 16. PubMed ID: 9219488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'.
    Haddad PM; Devarajan S; Dursun SM
    J Psychopharmacol; 2001 Jun; 15(2):139-41. PubMed ID: 11448088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discontinuation symptoms in depression and anxiety disorders.
    Baldwin DS; Montgomery SA; Nil R; Lader M
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):73-84. PubMed ID: 16359583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant withdrawal reactions.
    Wolfe RM
    Am Fam Physician; 1997 Aug; 56(2):455-62. PubMed ID: 9262526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar discontinuation symptoms for withdrawal from medium-dose paroxetine and venlafaxine after nine years in the same patient.
    Kotzalidis GD; de Pisa E; Patrizi B; Savoja V; Ruberto G; Girardi P
    J Psychopharmacol; 2008 Jul; 22(5):581-4. PubMed ID: 18208915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newer antidepressants and the discontinuation syndrome.
    Haddad P
    J Clin Psychiatry; 1997; 58 Suppl 7():17-21; discussion 22. PubMed ID: 9219489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should children take antidepressants?
    Harv Ment Health Lett; 2003 Dec; 20(6):5-7. PubMed ID: 14690974
    [No Abstract]   [Full Text] [Related]  

  • 9. [Taperingstrips for paroxetine and venlafaxine].
    Groot PC;
    Tijdschr Psychiatr; 2013; 55(10):789-94. PubMed ID: 24194351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
    J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid weight gain associated with edema after use of paroxetine and venlafaxine: 2 case reports.
    Uguz F
    Clin Neuropharmacol; 2014; 37(1):34-5. PubMed ID: 24434531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database.
    Gastaldon C; Schoretsanitis G; Arzenton E; Raschi E; Papola D; Ostuzzi G; Moretti U; Seifritz E; Kane JM; Trifirò G; Barbui C
    Drug Saf; 2022 Dec; 45(12):1539-1549. PubMed ID: 36400895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving antidepressant adherence.
    Nemeroff CB
    J Clin Psychiatry; 2003; 64 Suppl 18():25-30. PubMed ID: 14700452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venlafaxine withdrawal syndrome.
    Sabljić V; Ružić K; Rakun R
    Psychiatr Danub; 2011 Mar; 23(1):117-9. PubMed ID: 21448114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant discontinuation syndrome.
    Antai-Otong D
    Perspect Psychiatr Care; 2003; 39(3):127-8. PubMed ID: 14606234
    [No Abstract]   [Full Text] [Related]  

  • 16. How many of 1829 antidepressant users report withdrawal effects or addiction?
    Read J; Cartwright C; Gibson K
    Int J Ment Health Nurs; 2018 Dec; 27(6):1805-1815. PubMed ID: 29873165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Food and Drug Administration warnings on antidepressant use in a national sample.
    Olfson M; Marcus SC; Druss BG
    Arch Gen Psychiatry; 2008 Jan; 65(1):94-101. PubMed ID: 18180433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal venlafaxine discontinuation syndrome: A mini-review.
    Holland J; Brown R
    Eur J Paediatr Neurol; 2017 Mar; 21(2):264-268. PubMed ID: 27931774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do drug warnings and market withdrawals have an impact on the number of calls to teratogen information services?
    Sheehy O; Gendron MP; Martin B; Bérard A
    Pharmacopsychiatry; 2012 Jun; 45(4):146-51. PubMed ID: 22290204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mania associated with venlafaxine discontinuation.
    Fava GA; Mangelli L
    Int J Neuropsychopharmacol; 2003 Mar; 6(1):89-90. PubMed ID: 12899740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.